- Home
- MEC vs LRMR Comparison
MEC vs LRMR Comparison
Compare MEC & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- LRMR
- Stock Information
- Founded
- MEC 1945
- LRMR N/A
- Country
- MEC United States
- LRMR United States
- Employees
- MEC N/A
- LRMR N/A
- Industry
- MEC Industrial Specialties
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- LRMR Health Care
- Exchange
- MEC Nasdaq
- LRMR Nasdaq
- Market Cap
- MEC 370.6M
- LRMR 426.9M
- IPO Year
- MEC 2019
- LRMR N/A
- Fundamental
- Price
- MEC $16.95
- LRMR $4.17
- Analyst Decision
- MEC Strong Buy
- LRMR Strong Buy
- Analyst Count
- MEC 3
- LRMR 8
- Target Price
- MEC $20.67
- LRMR $19.63
- AVG Volume (30 Days)
- MEC 87.6K
- LRMR 1.0M
- Earning Date
- MEC 11-05-2024
- LRMR 10-30-2024
- Dividend Yield
- MEC N/A
- LRMR N/A
- EPS Growth
- MEC 53.85
- LRMR N/A
- EPS
- MEC 0.59
- LRMR N/A
- Revenue
- MEC $608,880,000.00
- LRMR N/A
- Revenue This Year
- MEC $0.34
- LRMR N/A
- Revenue Next Year
- MEC $0.73
- LRMR N/A
- P/E Ratio
- MEC $28.28
- LRMR N/A
- Revenue Growth
- MEC 7.13
- LRMR N/A
- 52 Week Low
- MEC $11.07
- LRMR $3.01
- 52 Week High
- MEC $23.02
- LRMR $13.68
- Technical
- Relative Strength Index (RSI)
- MEC 47.98
- LRMR 26.41
- Support Level
- MEC $16.42
- LRMR $3.01
- Resistance Level
- MEC $17.49
- LRMR $6.91
- Average True Range (ATR)
- MEC 0.47
- LRMR 0.55
- MACD
- MEC 0.12
- LRMR -0.19
- Stochastic Oscillator
- MEC 65.42
- LRMR 31.28
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.